The Association Between Trajectories of Self-reported Psychotic Experiences and Continuity of Mental Health Care in a Longitudinal Cohort of Adolescents and Young Adults.

adolescent mental health services psychotic disorders psychotic symptoms transition to adult care young adult

Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
07 Aug 2024
Historique:
medline: 8 8 2024
pubmed: 8 8 2024
entrez: 8 8 2024
Statut: aheadofprint

Résumé

Young people (YP) with psychotic experiences (PE) have an increased risk of developing a psychiatric disorder. Therefore, knowledge on continuity of care from child and adolescent (CAMHS) to adult mental health services (AMHS) in relation to PE is important. Here, we investigated whether the self-reported trajectories of persistent PE were associated with likelihood of transition to AMHS and mental health outcomes. In this prospective cohort study, interviews and questionnaires were used to assess PE, mental health, and service use in 763 child and adolescent mental health service users reaching their service's upper age limit in 8 European countries. Trajectories of self-reported PE (3 items) from baseline to 24-month follow-up were determined using growth mixture modeling (GMM). Associations were assessed with auxiliary variables and using mixed models. Study results. At baseline, 56.7% of YP reported PE. GMM identified 5 trajectories over 24 months: medium increasing (5.2%), medium stable (11.7%), medium decreasing (6.5%), high decreasing (4.2%), and low stable (72.4%). PE trajectories were not associated with continuity of specialist care or transition to AMHS. Overall, YP with PE reported more mental health problems at baseline. Persistence of PE or an increase was associated with poorer outcomes at follow-up. PE are common among CAMHS users when reaching the upper age limit of CAMHS. Persistence or an increase of PE was associated with poorer mental health outcomes, poorer prognosis, and impaired functioning, but were less discriminative for continuity of care.

Sections du résumé

BACKGROUND AND HYPOTHESIS OBJECTIVE
Young people (YP) with psychotic experiences (PE) have an increased risk of developing a psychiatric disorder. Therefore, knowledge on continuity of care from child and adolescent (CAMHS) to adult mental health services (AMHS) in relation to PE is important. Here, we investigated whether the self-reported trajectories of persistent PE were associated with likelihood of transition to AMHS and mental health outcomes.
STUDY DESIGN METHODS
In this prospective cohort study, interviews and questionnaires were used to assess PE, mental health, and service use in 763 child and adolescent mental health service users reaching their service's upper age limit in 8 European countries. Trajectories of self-reported PE (3 items) from baseline to 24-month follow-up were determined using growth mixture modeling (GMM). Associations were assessed with auxiliary variables and using mixed models. Study results. At baseline, 56.7% of YP reported PE. GMM identified 5 trajectories over 24 months: medium increasing (5.2%), medium stable (11.7%), medium decreasing (6.5%), high decreasing (4.2%), and low stable (72.4%). PE trajectories were not associated with continuity of specialist care or transition to AMHS. Overall, YP with PE reported more mental health problems at baseline. Persistence of PE or an increase was associated with poorer outcomes at follow-up.
CONCLUSIONS CONCLUSIONS
PE are common among CAMHS users when reaching the upper age limit of CAMHS. Persistence or an increase of PE was associated with poorer mental health outcomes, poorer prognosis, and impaired functioning, but were less discriminative for continuity of care.

Identifiants

pubmed: 39113641
pii: 7729404
doi: 10.1093/schbul/sbae136
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Sophia Children's Hospital Research Foundation
ID : S19-34
Organisme : Netherlands Organization for Health Research and Development
ID : 60-63600-98-774
Organisme : European Commission's 7th Framework Programme
ID : 602442

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.

Auteurs

Suzanne E Gerritsen (SE)

Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, Rotterdam, the Netherlands.

Koen Bolhuis (K)

Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, Rotterdam, the Netherlands.

Larissa S van Bodegom (LS)

Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, Rotterdam, the Netherlands.
Yulius Mental Health Organization, Dordrecht, the Netherlands.

Athanasios Maras (A)

ARQ National Psychotrauma Centre, Diemen, the Netherlands.

Mathilde M Overbeek (MM)

ARQ National Psychotrauma Centre, Diemen, the Netherlands.
Department of Clinical Child and Family Studies, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Yulius Academy, Yulius Mental Health Organization, Dordrecht, the Netherlands.

Therese A M J van Amelsvoort (TAMJ)

Department of Psychiatry and Neuropsychology, University of Maastricht, Maastricht, the Netherlands.
Mondriaan Mental Health Care, Heerlen, the Netherlands.

Dieter Wolke (D)

Department of Psychology, University of Warwick, Coventry, UK.
Warwick Medical School, University of Warwick, Coventry, UK.

Giovanni de Girolamo (G)

IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Tomislav Franić (T)

University Hospital Split, Split, Croatia.
School of Medicine, University of Split, Split, Croatia.

Jason Madan (J)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.

Fiona McNicholas (F)

School of Medicine & Medical Science, University College Dublin, Dublin, Republic of Ireland.
Lucena CAMHS, SJOG, Dublin, Republic of Ireland.

Moli Paul (M)

Warwick Medical School, University of Warwick, Coventry, UK.
Coventry and Warwickshire Partnership NHS Trust, Coventry, UK.

Diane Purper-Ouakil (D)

Centre Hospitalier Universitaire de Montpellier, Saint Eloi Hospital, Montpellier, France.
INSERM, CESP U1018, PsyDev, University Paris Saclay, UVSQ, Versailles, France.

Paramala Santosh (P)

Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.
Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, London, UK.
HealthTracker Ltd, Kent, UK.

Ulrike M E Schulze (UME)

Department of Child and Adolescent Psychiatry/Psychotherapy, University of Ulm, Ulm, Germany.

Swaran P Singh (SP)

Warwick Medical School, University of Warwick, Coventry, UK.

Cathy Street (C)

Warwick Medical School, University of Warwick, Coventry, UK.

Sabine Tremmery (S)

Department of Neurosciences, KU Leuven, Leuven, Belgium.

Helena Tuomainen (H)

Warwick Medical School, University of Warwick, Coventry, UK.

Gwen C Dieleman (GC)

Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, Rotterdam, the Netherlands.

Esther Mesman (E)

Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, Rotterdam, the Netherlands.

Classifications MeSH